~~<i id='35B1AD2FCF'><strike id='35B1AD2FCF'><tt id='35B1AD2FCF'><pre id='35B1AD2FCF'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

hotspot

entertainment

author：leisure time 2025-10-02 13:40:42 - browse：451

For a decade, leading academic institutes and their associated companies fought a bruising, headline-grabbing fight over who held patent rights to CRISPR-Cas9, the revolutionary genome editing tool.

Editas Medicine, the winner of that battle in the U.S., will now cash in.

Vertex Pharmaceuticals and Editas announced Wednesday that Vertex will pay Editas $50 million, along with a series of annual payments through 2034, in exchange for rights to use CRISPR-Cas9 in Casgevy, the sickle cell therapy approved last week.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Affirmative action in medical school literally saved lives
Next article： Cloning humans is technically possible. It's curious no one has tried

entertainment

knowledge

hotspot

explore

hotspot

Wikipedia

Foodmakersdon'twantregulatorstofocusonultra-processedfoodswhentheygotoupdatedietaryguidelines.DanKit

WSS

How medical schools plan to diversify without affirmative action

Telehealth for opioid use disorder is lifesaving

How housing is health care on Long Island

CDC concerned about possible undetected monkeypox spread in U.K.

Hospitals consider fixing cancer drug shortages on their own

New guidelines on severe brain injury complicate already difficult decisions

hotspot

entertainment

entertainment

Alkermes shareholders re

Walmart eyes Medicare Advantage provider ChenMed

ChatGPT in medicine: STAT answers readers' burning questions

Gene therapy has helped boys walk. Can scientists keep it that way?

Continuity nursing helped my family in our darkest PICU moments

How medical schools plan to diversify without affirmative action

Peter Hotez and the public health issue of online harassment

Telehealth for opioid use disorder is lifesaving

Anesthesiologist group: stop taking Ozempic before surgery

FDA panel endorses Alnylam’s heart drug — after picking it apart

knowledge

STAT's guide to the next generation of CAR

New guidelines on severe brain injury complicate already difficult decisions

White House touts steps to stem shortages of cancer treatments

FDA approves updated Covid vaccines

Pig kidney works a record two months in donated body

Pig kidney works a record two months in donated body

hotspot

explore

hotspot

Wikipedia